Blog

  • ‘Clayface’ Teaser Trailer: First Look at DC Studios’ R-Rated Body Horror Film

    The Clayface teaser trailer has arrived.

    The first footage (below) from the high curiosity project from DC Studios follows an up-and-coming actor (Tom Rhys Harries) whose face is disfigured by a gangster. As a last resort, he turns to a scientist (Naomi Ackie) who transforms his body into clay.

    The body horror film from director James Watkins (Speak No Evil) is based on a script by Doctor Sleep director Mike Flanagan along with Hossein Amini. In February, DC Studios co-chief James Gunn told reporters that the studio, “had no plans [to make] a Clayface movie,” but then Flanagan “turned in a script and it’s one of the best scripts that we’ve read.”

    Like Todd Phillips’ 2019 hit Joker, the project will serve as an origin story for a Batman villain and is likewise expected to carry an R rating. Unlike Joker, and its 2024 sequel, the project is considered part of the DC Universe rather than its own self-contained world.

    Clayface might not be as widely known as The Penguin or The Joker, but we really feel that his story is equally resonant, compelling, and in many ways, more terrifying than one of those,” DC Studios co-chief Peter Safran has said, with Gunn adding the film will feel “totally real” and will be “true and psychological and body horror and gross.”

    Clayface is slated to take advantage of spooky season at the box office, hitting theaters on Oct. 23. First up for DC, however, is Supergirl, which takes flight on June 26. The duo are seen as the second wave of theatrical projects for Gunn and Safran since last year’s hit, Superman.

  • ‘Heart Eyes 2’ a Go for 2028 Release From Paramount, Spyglass

    ‘Heart Eyes 2’ a Go for 2028 Release From Paramount, Spyglass

    Paramount is doubling down on Heart Eyes. The studio has has set a Valentine’s Day weekend release date of Feb. 11, 2028.

    Paramount will co-produce and co-finance Heart Eyes 2 along with Spyglass Media Group and handle global distribution. (Sony had domestic on the first film, while Paramount handled international for the for the romantic slasher sequel.)

    Mason Gooding and Olivia Hoult starred in the first movie as co-workers mistaken for a couple by a killer who targets romantic partners on Valentine’s day. It earned $33.1 million globally after opening Valentine Day Weekend last year.

    Josh Ruben directed the first Heart Eyes and will return to direct and co-write the sequel script with Darcy Fowler, from a story by Christopher Landon and Michael Kennedy. (Landon and Kennedy wrote the script for the first movie with Phillip Murphy.) Landon and Divide/Conquer will produce the feature.

    At this stage, it’s too early to say if if Gooding or Hoult will return for the sequel. Ruben made the original film in near record time, pitching it on Valentine’s Day weekend in 2024, with the film arriving in theaters a year later. “We really hustled, and it’s truly a nine-month baby,” he told THR upon release. This time, there will be a little bit more breathing room to hit that 2028 date.

  • Russia Advances Sweeping Crypto Bill With Provisions for ‘Circumventing Sanctions’

    Russia Advances Sweeping Crypto Bill With Provisions for ‘Circumventing Sanctions’

    In brief

    • Russia’s State Duma passed comprehensive crypto regulation in its first reading.
    • The bill classifies cryptocurrency as property, enabling legal protection in court proceedings.
    • Cross-border crypto transactions are permitted; domestic payments remain prohibited.

    Russia’s State Duma passed a comprehensive crypto regulation bill in its first reading, establishing the country’s first formal framework for digital asset regulation while maintaining restrictions on domestic cryptocurrency payments.

    Per reports in local media, the legislation would classify cryptocurrency as property, enabling legal protection in court proceedings including bankruptcy and divorce cases. Non-qualified investors would face annual purchase limits of 300,000 rubles (around $3,900), while professional participants would encounter no such restrictions.

    Kaplan Panesh, deputy chairman of the State Duma Committee on Budget and Taxes, noted that while the ruble remains Russia’s sole legal settlement currency, the bill creates an exception for cryptocurrency use in foreign trade. “This allows Russian companies to use cryptocurrency to pay foreign counterparties, circumventing sanctions restrictions,” Panesh said.

    The Bank of Russia would serve as the licensing authority for crypto market participants under the proposed framework. The legislation is expected to take effect July 1, 2026, pending second and third readings in the State Duma, Federation Council approval, and presidential signature.

    The bill’s provisions for cross-border crypto transactions could provide Russian companies an alternative payment mechanism outside traditional banking systems that Western nations have restricted since Russia’s invasion of Ukraine. The legislation explicitly permits cryptocurrency settlements with foreign partners while maintaining domestic payment prohibitions, creating a regulatory pathway for international trade that circumvents conventional financial channels.

    Tuesday’s State Duma vote represents Russia’s most comprehensive attempt to formalize digital asset regulation, balancing cryptocurrency integration with state control over domestic monetary policy.

    Russia and crypto

    Russia’s crypto landscape continues to evolve in the face of the geopolitical upheaval sparked by its invasion of Ukraine, and the resulting sanctions imposed on the country.

    Russia banned cryptocurrency payments in 2020 while permitting digital asset ownership. The country has since opened limited pathways for institutional use and cross-border transactions amid Western sanctions following its invasion of Ukraine.

    A September 2025 report from blockchain forensics firm Elliptic found that one Russia-linked network was connected to at least $8 billion in stablecoin transactions over an 18-month period, specializing in “sanctions evasion as a service.”

    By January, transactions in ruble-pegged stablecoin A7A5 had topped $100 billion, while the 2026 TRM Crypto Crime Report found that A7A5 and its associated wallet network handled approximately $70 billion in sanctions-related flows in 2025.

    In February, the EU moved to ban all crypto transactions with entities based in Russia, in response to the relaunching of sanctioned Russian crypto providers under different names—as in the case of shuttered Russian exchange Garantex, which reemerged last year as Grinex.

    Earlier this month, Grinex halted trading after alleging a $13 million exploit by what it termed “Western special services.”

    Daily Debrief Newsletter

    Start every day with the top news stories right now, plus original features, a podcast, videos and more.

  • Annecy Festival Rolls Out Inaugural Slate for New International Animation Institute

    Annecy Festival Rolls Out Inaugural Slate for New International Animation Institute

    Annecy Animation Film Festival is rolling out a slate of events to mark its 2026 edition and the opening of its sprawling new institute, including a showcase for Laika, the studio behind “Coraline” and “The Boxtrolls,” and an exhibition dedicated to Ankama (“Krosmoz”).

    Annecy is already considered the world’s leading animation festival. The new hub, called Cité Internationale du Cinema d’Animation, will now expand Annecy’s reach beyond its annual festival and reinforce its status as a global animation platform.

    The site will open on June 19 with an inaugural exhibition, “Ankama: From Sketch to Epic — 25 Years of Creation.” The immersive showcase – running through January 2027 — will explore the studio’s “Krosmoz” universe across animation, video games and publishing, tracing its creative journey from early sketches to finished works.

    The exhibition around Laika, meanwhile, will bring its CEO, filmmaker Travis Knight, on the ground in Annecy where he will present early footage from “Wildwood,” one of the most anticipated animated films in the pipeline. .

    A year-round cultural and educational hub, the Cité Internationale du Cinema d’Animation boasts a vast screening room, an artists’ residency, special areas for training courses and cultural action, alongside exhibition spaces, a bookstore and a gift shop. It’s located in a 19th century landmark called Haras, which spreads over 2.6 acres of lush gardens and buildings listed as French historic monuments.

    Mickaël Marin, the director of Annecy festival and its industry market MIFA, previously told Variety that the idea behind the venue was to “create a cultural hub like the French Cinematheque in Paris or the Lumiere Institute in Lyon, which will bring together animation lovers and artists from all around the world.”

    As Gaëtan Bruel, the president of the National Film Board, pointed it, “The Annecy Festival is not only the world’s leading animation event, but also the third-largest event of its kind across all genres.”

    “Together with the Cité internationale du cinéma d’animation, our goal is to build on these achievements and take things even further by making Annecy and its region the year-round global capital of animation,” he added.

    Dominique Puthod, president of CITIA, the festival’s organizing body, said, “The Cité is a place for today — and above all for tomorrow. It’s a place for young people, where animation becomes a living heritage shared by all.” He added, “Animation is not a minor form of cinema, but an art in its own right — a universal language that connects generations.”

    Education will be a core pillar at the Cité Internationale du Cinema d’Animation, with spaces such as the “Grenier à images” offering workshops and programs designed to help younger audiences understand how images are made and how to engage with them.

    “With the opening of the Cité, Annecy fully asserts its status as the world capital of animation,” said Antoine Armand, describing the project as a “major milestone” that strengthens a “unique ecosystem” and boosts the city’s international reach.

  • ‘Heart Eyes 2’ Sets February 2028 Release Date at Paramount

    ‘Heart Eyes 2’ Sets February 2028 Release Date at Paramount

    Heart Eyes Killer, the deranged murderer who strikes on Valentine’s Day, has staked a big-screen return.

    Paramount Pictures will co-produce and co-finance “Heart Eyes 2,” with a release date set for Feb. 11, 2028. Sony Pictures had distributed the first film, which earned $33 million at the global box office against an $18 million budget in 2025.

    Olivia Holt and Mason Gooding starred in “Heart Eyes” as two co-workers who are mistaken for lovers by a serial killer whose modus operandi is slaying couples on the most romantic holiday of the year. Gigi Zumbado, Michaela Watkins, Devon Sawa, and Jordana Brewster rounded out the cast. It’s unclear who from that group is returning for the sequel. Plot details haven’t been revealed, either.

    Josh Ruben is back to direct “Heart Eyes 2.” He will also co-write the script with Darcy Fowler from a story by Christopher Landon and Michael Kennedy. Spyglass Media co-produced and co-financed “Heart Eyes” and the sequel. Landon and Divide/Conquer will also serve as producers.

    “Heart Eyes” wasn’t exactly a box office smash, but reviews were solid for the horror genre. Variety’s Courtney Howard praised the film as a a breezy rom-com slasher that slices and dices with charm,” adding that “‘Heart Eyes’ makes us swoon and squirm in equal measure.”

    Last year, Ruben suggested the”Heart Eyes” franchise has the “potential for a long life.”

    “I’ll put it this way: You could replicate the structure of any great rom-com, from ‘His Girl Friday’ to ‘Defending Your Life,’ and you could drop Heart Eyes into the center of that story, and have him flash and slash about,” he said. “That’s what’s exciting about this: There’s an opportunity that we could have whoever the filmmaker was — certainly, I’d be interested — genuinely trying to create or replicate that rom-com, or the feeling of a “Bridget Jones” or “Love Actually” or what have you, but actually have those people terrified by this psychopathic killer.”

  • Anthony Pompliano Claims the Bitcoin Bull Market Has Begun – “The Sling Shot Effect Is Coming”

    Anthony Pompliano Claims the Bitcoin Bull Market Has Begun – “The Sling Shot Effect Is Coming”

    Renowned financial analyst Anthony Pompliano, in his latest analysis, claims that the Bitcoin bull market has already begun and issued an important warning to his followers.

    Noting that Bitcoin has experienced a pullback of approximately 40% from its peak of $126,000, Pompliano predicts that this decline will create a “slingshot effect” leading to new highs.

    Pompliano argues that Bitcoin has proven its worth to institutional investors. In seven consecutive financial crises since 2020, Bitcoin has outperformed stocks, gold, and cash, becoming the most profitable asset.

    From pandemics to wars, banking crises to high inflation, he argues that Bitcoin has become the “king of safe havens” in all kinds of chaos.

    Related News BREAKING: Cryptocurrency Exchange Coinbase Lists a Surprise Altcoin

    Citing a new report published by Bitwise, Pompliano argued that an investor who holds Bitcoin for at least three years has less than a 1% chance of losing money.

    The analyst argues that a historic period is underway not only for cryptocurrencies but also for stock markets. He added that the signal he calls the “3-3-3 rule” (the stock market rising by 3% or more for three consecutive weeks) has only occurred three times in the last 76 years.

    Referring to the impact of the upcoming US elections on the markets, Pompliano predicts that the current administration will do everything in its power to keep the economy afloat and boost asset prices before the election.

    *This is not investment advice.

  • The question isn’t whether privacy. It’s what sort of privacy

    Blockchains were built as public networks in the best tradition of open-source technology. But their future is private. And that future is arriving faster than most people realize.

    This month, Tempo — the Stripe-backed payment blockchain that raised $500 million at a $5 billion valuation, with Visa, Mastercard, Paradigm, and UBS among its backers — published a detailed architectural proposal for private enterprise stablecoin transactions. Tempo is not a scrappy privacy-native project. It is arguably the most institutionally credentialed blockchain launch in years, built by people who deeply understand what banks, payment processors, and enterprises actually need. When a network with that pedigree makes privacy a launch-week priority, it isn’t a signal. It’s a verdict.

    The question of whether or not institutional chains will be private has been settled. What remains is the harder one: what kind of privacy are we actually building?

    The problem with public chains

    Bitcoin solved a problem that had stumped computer scientists and bankers for decades: how to transfer value between strangers without a trusted intermediary. Ethereum took blockchains further, offering programmable value alongside value transfer — smart contracts that could encode agreements, automate settlement, and eliminate entire categories of middlemen. Then came stablecoins, which married programmability to the stability of the dollar, and from there, the migration of real-world assets to onchain protocols began.

    Each wave has brought added institutional interest, capital, and ambition. And now, as regulatory clarity emerges, institutions are ready to deploy resources onchain.

    But there’s one thing holding them back — a fundamental flaw that becomes more consequential the larger the numbers get.

    Everything is visible. Every wallet. Every balance. Every transaction, in real time, is readable by anyone with a browser. In financial markets, this is not a feature. It is an existential problem. Imagine if every hedge fund’s positions, every corporate treasury’s holdings, every pension fund’s rebalancing trade appeared on a public screen the moment it was executed. Sophisticated counterparties would front-run. Competitors would map your strategy. Criminals would identify targets. The financial system as it exists today would seize up overnight.

    Blockchains have been asking institutions to accept exactly that. Tempo’s announcement on April 16 is the clearest possible signal that institutions have finally said: no.

    Architecture is destiny

    Here is where the conversation gets more consequential — and more nuanced.

    Tempo’s solution is Zones: private parallel blockchains connected to the main network. Within a Zone, participants transact privately. The public sees only cryptographic proofs of validity, not underlying data. Compliance controls travel with the token automatically. Assets remain interoperable with Tempo Mainnet. For enterprises running payroll, treasury operations, or settlement workflows, it is a thoughtful and practical design.

    But Tempo’s privacy model is operator-visible. The Zone operator — an enterprise or infrastructure provider — sees all transactions within its Zone. The public sees nothing. The operator sees everything. For many regulated institutions, this is acceptable, and may even be required. But it means privacy is contingent on trusting an intermediary. You have moved the visibility problem; you have not eliminated it.

    This is not a criticism of Tempo. It is a description of a genuine architectural choice — one with real consequences for anyone thinking carefully about risk.

    Zero-knowledge cryptography offers a different path. ZK proofs allow a party to prove that a transaction is valid without revealing the underlying data. A new generation of ZK-native blockchains builds this privacy-preserving functionality into the execution layer itself. Accounts execute transactions locally, with the chain storing only a cryptographic commitment. Nothing sensitive ever touches a public ledger. Transaction history is not browsable. And crucially, no operator has a god’s-eye view — privacy is enforced at the base layer, not delegated to an intermediary.

    If Bitcoin gave us trustless transfer and Ethereum gave us programmable trust, ZK-native blockchains offer verifiable privacy: the ability to prove that everything happened correctly without revealing what actually happened.

    Compliance without full transparency

    The obvious objection is regulatory. Privacy and compliance have long been framed as incompatible — oil and water. That framing is becoming obsolete.

    Regulatory compliance does not require that everyone can see your transactions. It requires that the right parties, under the right conditions, can verify that your transactions were legitimate. That is a meaningful distinction, and it is one that ZK cryptography is uniquely positioned to enforce. Selective, programmable disclosure — revealing what regulators need to see, nothing more — is not a workaround. It is a more precise implementation of what compliance actually demands.

    Tempo’s model handles this at the operator level. ZK-native approaches handle it at the cryptographic level. Both satisfy the compliance requirement. But they distribute trust very differently.

    The question that matters

    The financial industry knows it needs to move onchain. It now knows — Tempo’s announcement makes this undeniable — that it cannot do so on fully public infrastructure. The era of public-by-default blockchains as the assumed standard for institutional finance is ending.

    What comes next depends on a choice the industry is only beginning to make clearly: privacy through trusted operators, or privacy through cryptographic guarantees that require no trust at all.

    Both are legitimate answers. But they are not equivalent. The privacy model you choose determines your risk surface, your compliance posture, and your exposure to the failure modes of the intermediaries you depend on. Architecture is not a technical detail to be resolved later. It is the decision that determines everything else.

    The question for the industry is not whether privacy. That debate is over.

    The question is what sort of privacy — and who, if anyone, you are willing to trust with the view.

  • Iran says ‘fully prepared’ for football team’s World Cup participation

    Iran says ‘fully prepared’ for football team’s World Cup participation

    Tehran says all necessary arrangements has been made for participation in the tournament cohosted by the US.

    Iran says that the country’s institutions are fully prepared for its national football team’s participation in the 2026 FIFA World Cup in the United States, Canada and Mexico.

    In a statement made to state broadcaster IRIB, government spokesperson Fatemeh Mohajerani said on Wednesday that the Ministry of Youth and Sports ensured all necessary arrangements for the team’s effective participation in the tournament.

    Recommended Stories

    list of 4 itemsend of list

    She also said the preparations were made under the directive of the sport minister, with a focus on providing the required facilities for a successful performance.

    FIFA President Gianni Infantino said on April 16 that Iran is expected to participate in the upcoming World Cup, taking place from June 11 to July 19, noting that the team has qualified and expressed its willingness to compete despite the ongoing US-Israeli war on Iran.

    “But Iran has to come, they represent their people, they have qualified, the players want to play,” he said of the Iranian team’s upcoming matches scheduled in the United States in June.

    “Sports should be outside of politics,” Infantino said.

    Group matches in the US

    US President Donald Trump said in March that while Iran’s team would be welcome at the tournament, he questioned whether it would be appropriate for them to attend, citing concerns over their “life and safety”.

    Iran is scheduled to play its three Group G matches in the United States – two in Los Angeles, one in Seattle – with their base for the tournament in Tucson, Arizona.

    Iran’s participation in the global tournament being cohosted by the three North American countries had been thrown into doubt by the conflict launched by the United States and Israel on February 28.

    Iran raised the prospect of a “boycott” of the competition before asking FIFA to move its matches from the United States to Mexico, a request the world governing body rejected.

    After several weeks of air strikes on Iran and Iranian reprisals against Israel and other countries in the region, a fragile truce came into effect on April 8.

    The announcement of the two-week ceasefire was followed by rare direct talks in Islamabad on April 11–12, which ended without an agreement. The ceasefire was later extended by the US as diplomatic efforts continue.

    The World Cup, the first to feature 48 teams, starts on June 11.

  • Aspirin Doesn’t Prevent Colorectal Cancer, Review Says. Here’s What Helps Instead

    Aspirin and a glass of waterShare on Pinterest
    A new study demonstrates limited protective benefits for daily aspirin use and colorectal cancer risk. Viktoriya Skorikova/Getty Images
    • Research suggests that daily low dose aspirin doesn’t appear to reduce a person’s risk of colorectal cancer.
    • Frequent aspirin use may increase a person’s risk of bleeding in and around the brain.
    • Experts say you can lower your colorectal cancer risk with lifestyle habits such as eating a plant-based diet, limiting alcohol consumption, and exercising daily.

    A daily regimen of low dose aspirin probably does not significantly reduce the risk of colorectal cancer but may increase the risk of bleeding in the brain area, according to a large-scale analysis of previous research.

    Researchers reported that daily aspirin probably does not help in preventing colorectal cancer in the first 15 years of use, although it might have some preventive benefits in the longer term.

    However, the researchers stated that they are “not confident” in the long-term assessment.

    They also reported that daily aspirin use may increase deaths from colorectal cancer in the short term but may help reduce deaths after 15 years.

    Again, the researchers noted they are “not confident” in these conclusions.

    They did report that daily aspirin use may increase the risk of bleeding outside the skull as well as bleeding in and around the brain.

    “It is not possible to draw definitive conclusions or outline specific implications for the routine use of aspirin for [colorectal cancer] primary prevention based on the current evidence,” the researchers wrote. “Our findings reveal complex, time‐dependent preventive effects and concerns about potential harms for clinicians and patients to consider.”

    Ketan Thanki, MD, a colorectal surgeon who specializes in benign and malignant disease of the colon, rectum, and anus at the MemorialCare Todd Cancer Institute at Long Beach Medical Center in California, said this latest report provides cautionary advice for anyone considering an aspirin regimen.

    “This study demonstrates limited (if any) protective benefit from aspirin on risk of developing colorectal cancer in the general population,” Thanki told Healthline. “With the known potential complications of long-term aspirin use, I would recommend that people don’t take daily aspirin solely with the intent of reducing your risk of developing colorectal cancer.”

    To reach their findings, the researchers analyzed data from 10 randomized controlled clinical trials.

    They compared aspirin and other nonsteroidal anti‐inflammatory drugs (NSAIDs) with either no treatment or a different treatment for preventing colorectal cancer or colorectal adenoma in the general population.

    The studies included more than 120,000 participants. Most of the research was conducted in North America and Europe. Low‐dose aspirin (75-100 mg per day) was typically used, although three studies evaluated higher doses.

    The researchers said they found that daily aspirin “probably results in little to no difference” in reducing colorectal cancer risks after 5 to 15 years of use. They added that aspirin might slightly reduce colorectal cancer risk after 15 years of use.

    “I would advise that you only consider daily aspirin for this purpose, either if you have a genetic syndrome that predisposes you to cancer (specifically Lynch Syndrome) or have had adenomatous polyps removed during a prior colonoscopy,” Thanki said.

    “In those populations, there is good evidence that it may decrease risk of cancer and may decrease risk of adenoma recurrence, respectively. Those patients should speak with their doctors.”

    The researchers also reported that daily aspirin “may increase mortality” from colorectal cancer between 5 and 10 years of use, as well as producing “little to no difference in mortality” between 10 and 15 years, and a possible reduction in mortality after 15 years.

    They added that aspirin “may result in little to no difference” in colorectal adenoma between 5 and 10 years, but “the evidence is very uncertain.”

    The researchers also noted that daily aspirin use produced “little to no difference’ in overall serious adverse events, but they said “aspirin does increase the risk of serious extracranial hemorrhage” and “probably increases the risk of hemorrhagic stroke.”

    The researchers said their findings should raise concerns for medical professionals and patients alike.

    “The uncertain and delayed potential for benefit must be weighed against a definite harm,” they wrote.

    “In light of the mixed evidence, clinical practice should continue to center on an individualized assessment and a shared decision‐making process, carefully balancing a patient’s established cardiovascular risk profile against their risk of bleeding,” the researchers wrote.

    There has been conflicting research in recent years over the benefits and the risks of daily aspirin use as a cancer prevention tool.

    The new research contradicts an August 2024 study that reported that regular aspirin use can lower the risk of colorectal cancer, especially in people who have obesity or have unhealthy lifestyle habits such as smoking.

    An April 2024 study also concluded that daily aspirin may have some protective benefits against colorectal cancer, perhaps by enhancing the body’s ability to detect cancer cells.

    However, a January 2026 study reported that daily aspirin did not appear to reduce cancer in older adults but stated it might increase the risk of cancer-related mortality in older population groups.

    The contrast in research has prompted at least one government agency to revise its recommendations.

    However, the task force withdrew its recommendation in 2022, citing a lack of evidence showing that daily aspirin reduces a person’s chance of developing or dying from colorectal cancer.

    Experts concur that people should consult with their doctor about whether daily aspirin is beneficial for them.

    “It may decrease the risk of… preeclampsia in high risk pregnancies, and, as we discussed, polyps and tumors in the colon. It is important to know that this is highly nuanced and you should always talk with your doctor to see if daily aspirin use is right for you,” he explained.

    Katherine Van Loon, MD, a specialist in gastrointestinal cancers at the University of California San Francisco, said the January 2026 study indicates that a patient’s age can be a determining factor in whether daily aspirin use should be initiated.

    “Age of aspirin initiation also seems to play a role and younger patients may benefit more,” she told Healthline in an earlier interview. “For now, I think we can say that we shouldn’t initiate aspirin therapy in an older adult for the sole purpose of cancer prevention.”

    • eating more plant-based foods
    • consuming less red meat and processed meat
    • limiting alcohol consumption
    • quitting smoking
    • maintaining a healthy weight
    • exercising daily

    “A lifestyle of moderation is most important in reducing your risk of colorectal cancer,” he said. “Diet and exercise are the best and easiest ways you can decrease your cancer risk.”

    Daily exercise and weight reduction are also key. Try avoiding tobacco use,” he added. “Lastly, get your screening tests done. Colonoscopy is the best way to prevent and detect cancer, but other modalities like Cologuard are also now available.”

    Van Loon shared a similar philosophy.

  • Vampire Survivors developer Poncle is opening more studios and has over 15 games in the works

    Vampire Survivors developer Poncle has big plans for the future, according to an interview The Game Business conducted with the company’s chief strategy officer Matteo Sapio. It’s opening two new studios in Japan and Italy and has over 15 games in active development. That’s a lot of action for a company primarily known for one franchise.

    Sapio says the company is developing three basic types of games. There are spinoffs to Vampire Survivors, like this week’s deckbuilder Vampire Crawlers. Poncle is also making original IPs and says there are two games set in new universes coming down the pike.

    Finally, it’s working on some roguelites with similar mechanics to Vampire Survivors, but using other IPs. We already know about one of these, a roguelite set in the Warhammer 40K universe called Warhammer Survivors. It’s set to land on Steam sometime this year. To assist with these plans, Poncle has developed an engine that can turn pre-existing IPs into games that play like Vampire Survivors.

    If you’re wondering if there are enough fans for multiple top-down roguelites with simple controls and bullet hell mechanics, let me point you to Halls of Torment, Deep Rock Galactic: Survivor and Soulstone Survivors, among many others. This has become a popular genre in recent years, likely due to the continued success of Vampire Survivors. To that end, the original game has surpassed 27 million players.

    Poncle has, however, paused all of its third-party publishing plans after releasing a couple of games last year. “It was a learning experience,” Sapio said. “But we found that we weren’t able to give the right support.” The company could revisit third-party publishing in the future.

    This is great news for Poncle and fans of the Vampire Survivors franchise, but there’s always risk when a company tries to grow like this. Remember Embracer Group? It went on a massive buying spree beginning in 2019, before having to sell off and close a number of studios.

    However, this isn’t a AAA game development studio. Poncle makes indie titles and the new studios will be lean operations, with “little teams of people.” Sapio said this organizational structure will help keep the company “agile and flexible.”

    I personally have high hopes for this endeavor. This is because the just-released spinoff Vampire Crawlers is so very good, which proves to me that Poncle isn’t a one-trick pony. It plays like a mix of Slay the Spire with a first-person dungeon crawler like Etrian Odyssey, all while successfully capturing the vibe of Vampire Survivors. If Poncle can keep up this level of quality, gamers could be in for a long-term treat.